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Abstract
Background: The efficacy of antenatal corticosteroid treatment for women with threatened preterm birth depends
on timely administration within 7 days before delivery. We modelled the probability of delivery within 7 days of
admission to hospital among women presenting with threatened preterm birth, using routinely collected clinical
characteristics.
Methods: Data from the Canadian Perinatal Network (CPN) were used, 2005–11, including women admitted to
hospital with preterm labour, preterm pre-labour rupture of membranes, short cervix without contractions, or
dilated cervix or prolapsed membranes without contractions at preterm gestation. Women with fetal anomaly,
intrauterine fetal demise, twin-to-twin transfusion syndrome, and quadruplets were excluded. Logistic regression
was undertaken to create a predictive model that was assessed for its calibration capacity, stratification ability, and
classification accuracy (ROC curve).
Results: We included 3012 women admitted at 24–28 weeks gestation, or readmitted at up to 34 weeks gestation,
to 16 tertiary-care CPN hospitals. Of these, 1473 (48.9%) delivered within 7 days of admission. Significant predictors
of early delivery included maternal age, parity, gestational age at admission, smoking, preterm labour, prolapsed
membranes, preterm pre-labour rupture of membranes, and antepartum haemorrhage. The area under the ROC
curve was 0.724 (95% CI 0.706–0.742).
Conclusion: We propose a useful tool to improve prediction of delivery within 7 days after admission among
women with threatened preterm birth. This information is important for optimal corticosteroid treatment.
Keywords: Preterm birth, Prediction model, Antenatal corticosteroids
Background
Preterm birth is the leading cause of perinatal mortality
and morbidity in Canada and worldwide [1, 2]. One the
most effective means to reduce neonatal mortality and
morbidity in preterm infants is antenatal administration of
corticosteroids [3, 4]. The proven benefits of antenatal
corticosteroids for fetal lung maturation and prevention of
serious neonatal morbidity among women with preterm
delivery have resulted in the inclusion of corticosteroid
treatment as standard obstetric care in industrialised
countries [3, 5–7]. Treatment guidelines recommend ad-
ministering corticosteroids to women who are at risk of
delivering within the next 7 days when they present
between 24+0 and either 33+6 weeks gestation in Canada
[5] and the United States [6], or up to 35+6 weeks gesta-
tion in the United Kingdom [7].
One of the major barriers to appropriate use of ante-
natal corticosteroids is that timing of delivery is often
unknown; approximately half of women who are admitted
to hospital with threatened preterm birth remain undeliv-
ered after 7 days [8, 9]. This makes it difficult to maximise
‘optimal’ use of corticosteroids (i.e., administration to
women who go on to deliver within the next 7 days and
not administering them to women who do not deliver
within the next 7 days). A recent study from Nova Scotia,
Canada, showed that between 1988 and 2012, the propor-
tion of women with suboptimal antenatal corticosteroid
treatment (i.e., more than 7 days prior to delivery)
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increased approximately 5 times (from 7% to 34%) whereas
optimal treatment doubled (from 10% to 23%) [10].
Until recently, administration of a single course of ste-
roids at <34 weeks was considered both effective and
safe. Increasingly, however, concerns have emerged
about adverse effects following multiple courses and side
effects following a single course administered in the
community in under-resourced settings [11–17]. Multiple
antenatal corticosteroid exposure at preterm gestation has
been found to affect fetal growth and CNS development
[11–14], and to be associated with neurosensory dysfunc-
tion in particular among infants born at term [15, 16]. In a
recent cluster randomised controlled trial in low- and
middle-income countries (LMICs), community adminis-
tration of antenatal corticosteroids for threatened preterm
birth before 36 weeks was associated with no benefit of
antenatal corticosteroids among babies born preterm, and
with a 12% increase in neonatal mortality and a 45%
increase in suspected maternal infection [17].
Actual corticosteroid treatment rates vary widely,
depending in part on maternal and obstetrical charac-
teristics [4] and the difficulty in predicting preterm
birth [18, 19]. Most literature focuses on predictors as
individual tests [20, 21] or clinical biomarkers; [20, 22]
however, they have not been found to be as useful in
predicting preterm birth among asymptomatic or nul-
liparous women, even when combined [21–24]. There
is a paucity of literature on prediction models that
combine multiple determinants of preterm birth, particu-
larly within 7 days of admission. Moreover, there is a lack
of models that use characteristics that are available upon
admission. Thus, based on clinical characteristics collected
in routine clinical practice, we aimed to identify women
who were likely to deliver within 7 days after admission to
hospital due to a high-risk of preterm delivery.
Methods
We carried out a retrospective cohort study of women ad-
mitted to any of the 16 perinatal centers participating in
the Canadian Perinatal Network (CPN) (Additional file 1).
The CPN study collected demographic, clinical, and
birth information on women who were both at high-
risk of very preterm birth between 22+0 and 28+6 weeks
gestation and admitted (or re-admitted) to the partici-
pating CPN tertiary hospitals for at least 24 h from
August 1, 2005 to March 31, 2011. These women were
followed-up until delivery.
The CPN database collected information on maternal
demographic and behavioural characteristics (e.g., mater-
nal age, marital status, smoking history, parity), past med-
ical and obstetric history (e.g., number of prior abortions
and preterm births), characteristics of current pregnancy
(e.g., fertility treatments, use of drugs or alcohol in preg-
nancy, reason for admission to hospital), maternal and
fetal surveillance and treatments (e.g., expectant care, use
of antibiotics, or partial or completed courses and sub-
sequent courses of corticosteroids), and pregnancy out-
comes. CPN details including data definitions have
been published previously [25]. Ethics approval was
obtained centrally as a quality assurance project by the
Research Ethics Boards at the University of British
Columbia (H05–70359) and at each study site. As such,
written consent was not required, and any collected infor-
mation was anonymised and de-identified prior to analysis.
In the current study, we included women in the CPN
database who presented between 24+0 and 28+6 weeks ges-
tation with one or more of the following conditions at
enrollment: preterm labour, preterm pre-labour rupture of
membranes (PPROM), short cervix without uterine con-
tractions, dilated cervix or prolapsed membranes without
uterine contractions on admission (see Additional file 2
for definitions). We also included women who were
admitted for these conditions occurring de novo at up to
34+6 weeks after previous admission to the CPN network
for other reasons, as these women would also be eligible
to receive corticosteroids. We excluded women whose
pregnancies were complicated by intrauterine fetal demise
at the time of admission, twin-to-twin transfusion syn-
drome, those with quadruplets, and known fetal anomaly
due to differences in their clinical management [26].
To create a generalisable model, it is recommended
that highly subjective factors or those dependent on the
health care system, local practice, or individual practi-
tioners should not be considered as predictors [27, 28].
Therefore, we did not include the following variables as
candidate predictors in our study: transfer to another
facility, use of cervical cerclage, tocolytic and antibiotic
treatment, and the fetal fibronectin test administered
before admission.
Unadjusted associations between candidate predictors
and delivery within 7 days were tested using chi-square
and Fisher’s exact test (as appropriate for categorical
variables), or the Student’s t-test or Wilcoxon non-
parametric test (as appropriate for continuous variables).
For the initial multivariable logistic regression model, we
selected candidate predictors that were either associated
with delivery within 7 days at p < 0.10 [29], or for face
validity, were known to be clinically relevant to preterm
birth (including alcohol use during pregnancy, and pre-
vious preterm birth) (Table 1) [30–32]. Potential interac-
tions between candidate predictors were examined. In
the multivariable model, the association between deliv-
ery within 7 days and candidate predictors that were
continuous (i.e., maternal age and gestational age) was
examined using clinically meaningful categories, product
terms, and splines where necessary. Missing values for
all variables in the model were imputed using the MICE
method of multiple imputation [29, 33]. This method
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Table 1 Demographic and clinical characteristics of women admitted to a tertiary hospital at 24–34 weeks gestation
Delivery within 7 days (N = 1473) Delivery in >7 days (N = 1539) p valuea
Baseline Demographic and Medical/Surgical History
Maternal age on admission (years)a
< 20 74 (5.0%) 45 (2.9%)
20–24 219 (14.9%) 213 (13.8%)
25–29 403 (27.4%) 404 (26.3%)
30–34 466 (31.6%) 509 (33.1%) 0.002
35–39 260 (17.7%) 275 (17.9%)
40–44 43 (2.9%) 79 (5.1%)
≥ 45 8 (0.5%) 14 (0.9%)
Nulliparousa 811 (55.1%) 699 (45.4%) <0.001
Prior miscarriagea 432 (29.3%) 514 (33.4%) 0.018
Prior therapeutic abortion 227 (15.4%) 231 (15.0%) 0.798
Prior birth at <37 weeks 213 (14.5%) 321 (20.9%) 0.013
Prior birth at 34–36 weeksa 82 (5.6%) 131 (8.5%) 0.090
Prior birth at <34 weeksa 161 (10.9%) 190 (12.3%) 0.476
Pre-existing medical conditions
Pre-existing hypertensiona 26 (1.8%) 48 (3.1%) 0.023
Pre-existing diabetes mellitus 20 (1.4%) 24 (1.6%) 0.757
Uterine structural abnormalitiesa,c 73 (5.0%) 94 (6.1%) 0.193
Renal disease/urologya 7 (0.5%) 20 (1.3%) 0.027
Rheumatic disease 14 (1.0%) 8 (0.5%) 0.241
Cardiac disease 10 (0.7%) 14 (0.9%) 0.612
Cervical procedures 17 (1.2%) 21 (1.4%) 0.723
Otherb 202 (13.7%) 261 (17.0%) 0.016
Smoking after pregnancy diagnoseda 321 (21.8%) 265 (17.2%) 0.002
Missing 18 (1.2%) 5 (0.3%)
Alcohol use during pregnancy (socially or at least twice weekly)a 43 (2.9%) 42 (2.7%) 0.838
Missing 19 (1.3%) 11 (0.7%)
Illicit drug use after pregnancy diagnoseda 69 (4.7%) 52 (3.4%) 0.083
Missing 19 (1.3%) 7 (0.5%)
Current pregnancy
GA on admissiona (weeks)
24 + 0–25 + 6 520 (35.3%) 602 (39.1%)
26 + 0–27 + 6 593 (40.3%) 616 (40.0%)
28 + 0–29 + 6 329 (22.3%) 311 (20.2%) <0.001
30 + 0–31 + 6 10 (0.7%) 7 (0.5%)
32 + 0–34 + 6 21 (1.4%) 3 (0.2%)
Multiple pregnancya 256 (17.4%) 380 (24.7%) <0.001
Twins 237 (16.1%) 343 (22.3%)
Triplets 19 (1.3%) 37 (2.4%)
Reasons for admission
Preterm laboura 776 (52.7%) 489 (31.8%) <0.001
Preterm pre-labour rupture of membranesa 597 (40.5%) 483 (31.4%) <0.001
Short cervix without contractionsa 125 (8.5%) 548 (35.6%) <0.001
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assumes data are missing at random; to test this assump-
tion, the cases with complete data were compared to
cases with missing variables. Imputation models were
built including all possible predictors of the variable to
be imputed and the outcome variable. This was done
five times to generate five completed datasets with
plausible values for the missing variable.
Backward selection was used to remove candidate
predictors that were not significantly associated with
birth within 7 days (Wald statistic p > 0.05) to obtain
the final model [34].
The diagnostic performance of the final model was
assessed in terms of calibration capacity, stratification
capacity, and classification accuracy [34]. Our goal was
to develop a pragmatic model with high sensitivity, low
false negative rate (of <5% based on the precedent set by
prenatal diagnostic screening) [35–37], and also high
negative predictive value (NPV), to best identify women
for whom an immediate administration of steroids may
be suboptimal. Calibration capacity was assessed by a
calibration curve that indicated whether the proportion
of women who delivered within 7 days in each group of
deciles of modeled probability corresponded to the pre-
dicted probability. Risk stratification capacity was
assessed by a classification table that showed whether
the model had the capacity to distinguish between high-
and low-risk groups, and whether these categories were
clinically meaningful. Finally, classification accuracy was
assessed by the extent to which the women who deliv-
ered within 7 days had an increased predicted probabil-
ity of doing so, and whether women who delivered
beyond 7 days had a low predicted probability of delivery
within 7 days (i.e., sensitivity and specificity, receiver oper-
ating characteristic [ROC] curve). Internal validation of
the model was performed using a bootstrap method on
the model development set with 200 iterations to generate
bias-corrected ROC and calibration curves.
Sensitivity analyses included assessment of other pre-
existing medical and/or surgical conditions that may be
associated with preterm birth, and the impact of missing
values on the predictive performance of the model by
excluding these cases. To ensure that the model
performed well for subgroups of women that may be
under-represented in our population, we tested the final
model’s accuracy separately for women with singleton vs.
multiple gestation, and for women admitted at 24–31 weeks
vs. 32–34 weeks gestation. All statistical analyses were
performed using R 3.1.1 (http://www.r-project.org).
Results
There were 3012 women with a primary admission at
24+0 to 28+6 weeks gestation or with a subsequent
admission up to 34+6 weeks gestation (after a previous
admission for other indications) who were eligible for
the study. Of these, 1473 (48.9%) women delivered
within 7 days of admission, while 1539 (51.1%) women
delivered after 7 days. Approximately one-third of
women (31.1%) delivered within 48 h (see Additional
file 3), and 14.2% of women delivered at term gestation.
Among women who delivered within 7 days of admis-
sion (N = 1473), 846 (57.4%) received steroids on
admission to hospital. Among those who delivered
more than 7 days after admission (N = 1539), 941
(61.1%) received steroids on admission to hospital and
598 (38.9%) did not receive steroids on admission to
hospital. Thus, 1444 (47.9%) women received optimal
therapy on admission with respect to steroids (by either
receiving it and delivering within 7 days [N = 846], or
not receiving it and not delivering within the next
7 days [N = 598]) and 1568 (52.1%) women received
suboptimal therapy on admission (by not receiving
steroids and delivering within 7 days [N = 627], or
receiving steroids and delivering more than 7 days later
[N = 941]). In routine practice, however, it is recognized
that a waiting period may be used after admission
because ongoing assessment allows for re-evaluation of
the need for antenatal corticosteroids. In our study, 74
women did receive antenatal corticosteroids after ad-
mission (day 1–7) and delivered within 7 days, while
138 women received antenatal corticosteroids after
Table 1 Demographic and clinical characteristics of women admitted to a tertiary hospital at 24–34 weeks gestation (Continued)
Dilated cervix or prolapsed membranes without contractionsa 241 (16.4%) 154 (10.0%) <0.001
Other associated complications/conditions at admission
Antepartum haemorrhagea 219 (14.9%) 123 (8.0%) <0.001
Gestational hypertension (any) 9 (0.6%) 4 (0.3%) 0.170
Gestational hypertension with proteinuria 7 (0.5%) 3 (0.2%) 0.217
Intrauterine fetal growth restriction 18 (1.2%) 25 (1.6%) 0.604
aFactors considered in the full model with a p value <0.10 (as highlighted in bold)
bOther conditions include intra-abdominal infection (N = 92), asthma (N = 162), neurologic disease (N = 47), STDs (N = 82), gastrointestinal disease (N = 23),
liver disease (N = 36), pre-existing thrombophilia (N = 22), pre-existing thromboembolism (N = 17), psychiatric disorders (N = 132), or other underlying medical
conditions (N = 27)
cIncludes leiomyomas (N = 84), bicornuate uterus (N = 54), unicornuate uterus (N = 5), didelphic uterus (N = 13), and other (N = 16)
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admission and delivered more than 7 days after the
steroid administration (decreasing the overall optimal
use to 45.6% and increasing overall suboptimal use to
54.4% in this cohort).
Demographic characteristics and obstetric history,
current pregnancy characteristics up to the time of admis-
sion, and maternal interventions during hospitalization
among women who delivered within 7 days from admis-
sion vs. those who delivered later are described in Table 1.
Women who delivered within 7 days after admission were
more likely to be younger, primiparous, have a history of
spontaneous abortion and preterm birth, have a single-
ton pregnancy, smoke during pregnancy, and be admit-
ted at higher gestational age. These women were also
more likely to be admitted for preterm labour, PPROM,
and dilated cervix or prolapsed membranes, and less
likely to be admitted with short cervix without contrac-
tions. They were more likely to have associated antepartum
haemorrhage.
As expected, adverse perinatal and maternal health
outcomes occurred more frequently among women who
delivered within 7 days, compared with those who deliv-
ered later (see Additional file 4). Only 200 (6.6%) women
had fibronectin testing data available, and 252 (8.4% over-
all, or 37.4% among women with a short cervix) had a
rescue or elective cerclage for short cervix.
There were no significant interactions identified
between candidate predictors. The final model included
eight variables whose associations with delivery within
7 days were significant. The crude and adjusted odds
ratios and 95% confidence intervals are presented in
Table 2. The predictive model equation was as follows:
Risk score =12.13 – [0.41 × Maternal age ≥ 40years] –
[1.08 × GA] + [0.02 × (GA)2] – [0.54 × Parity] + [0.32 ×
Smoking] + [2.00 × Preterm labour] + [1.72 × PPROM] +
[1.85 × Prolapsed membranes] + [0.67 × Antepartum
haemorrhage]; the probability of outcome (delivery
<7 days) = 1/(1 + e-risk score). Based on this model, for
example, a woman who is 35 years old, nulliparous, non-
smoking, and presents at 28 weeks’ gestation with PPROM
at admission would have, on average, a 34% probability of
delivery within 7 days, whereas the same woman present-
ing with PPROM and preterm labour would have a prob-
ability of 79%. Figure 1a displays a ROC curve for the final
model, with AUC = 0.724 (95% CI: 0.706–0.742).
The calibration curve (Fig. 1b) showed good calibra-
tion capacity of the final model, as the proportion of
women who delivered within 7 days in each risk cat-
egory corresponded to the predicted risk. Predicted
probabilities that were very low (<20%) and high (>80%)
were slightly overestimated.
The final model had a relatively good calibration and
stratification ability to distinguish between women with
high vs. low risk of delivering within 7 days (Table 3).
Among women with 0–15% predicted probability of de-
livery within 7 days, 6% delivered within 7 days, while
among those with ≥65% predicted probability, 75.4% de-
livered within 7 days. Among women who delivered
within 7 days, only 1% had a low probability of such deliv-
ery, while approximately 25% had a high probability.
Table 2 Risk factors included in the final model predicting delivery within 7 days of admission
Risk factor OR [95% CI] Adjusted ORa [95% CI]
Maternal age (yr)
< 40 Reference Reference
≥ 40 0.55 [0.39–0.78] 0.66 [0.45–0.97]
Parity
Nulliparous Reference Reference
Parity ≥1 0.68 [0.59–0.78] 0.58 [0.50–0.68]
Smoking during pregnancyb 1.35 [1.13–1.62] 1.37 [1.12–1.67]
Gestational age (GA) on admissionc 1.08 [1.03–1.13] c
Maternal conditions
Preterm labour 2.38 [2.05–2.76] 7.37 [5.85–9.29]
PPROM 1.52 [1.30–1.76] 5.59 [4.42–7.07]
Prolapsed membranes 1.75 [1.41–2.18] 6.36 [4.77–8.48]
Associated antepartum haemorrhage 2.06 [1.63–2.60] 1.96 [1.53–2.52]
OR odds ratio, PPROM preterm pre-labour rupture of membranes
aadjusted for all other factors presented in the table
bmissing values were imputed
cGestational age was modelled using higher order polynomials (see the equation below)
Equation:
Risk score =12.13 – [0.41 × Maternal age ≥ 40years] – [1.08 × GA] + [0.02 × (GA)2] – [0.54 × Parity] + [0.32 × Smoking] + [2.00 × Preterm labour] + [1.72 × PPROM] +
[1.85 × Prolapsed membranes] + [0.67 × Antepartum haemorrhage]
the probability of outcome (delivery <7 days) = 1/(1 + e-risk score)
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Different thresholds of probability were considered to
identify women unlikely to deliver within 7 days. Table 4
shows a good stratification ability of the model with
meaningful probability categories. We used probability
cut-offs as follows: ≤15% as our lowest threshold in
order to have a sufficient number of women included in
this category, <27% to minimise the false negative
rate to <5% (based on similar prenatal diagnostic test-
ing criteria) [35, 38], <50% to be better than the flip
of a coin, and ≥65% a threshold with a sufficient
number of women in this ‘high probability of delivery’
category. If the optimal cut-off point were to maxi-
mise negative predictive probability (NPV) with a
chosen acceptable false negative rate of <5%, the opti-
mal threshold of predicted probability would be ≤27%
(sensitivity 96.2% with the lower 95% CI limit of
95.1%; NPV of 89.0%, 95% CI 86.0–91.5). At this
threshold, corticosteroid treatment would be given to
2502 (83.1%) women and withheld from 510 (16.9%), with
treatment that would be optimal in 1871 (62.1%) women
and suboptimal in 1141 (37.9%), a significant difference
compared with values in our cohort of 47.9% and 52.1%,
respectively (p-value <0.001). The corresponding negative
likelihood ratio of 0.13 (95% CI 0.10–0.17) indicates a
highly informative test in terms of ruling out delivery
within 7 days. However, in practice, the predicted prob-
ability of delivery within 7 days would best be used as a
continuous value to customise management.
Internal validation of the final model using a bootstrap
method with 200 repetitions yielded an AUC optimism
of 0.004, with bias-corrected AUC = 0.720 (95% CI
0.702–0.738). The bias-corrected calibration curve did
not exhibit any appreciable changes compared with the
initial curve (see Additional file 5).
Fig. 1 Graphical presentation of prognostic performance of the final model to predict delivery within 7 days of admission among a high-risk
cohort. a Area under the ROC curve. b Calibration curve
De Silva et al. BMC Pregnancy and Childbirth  (2017) 17:202 Page 6 of 10
Sensitivity analyses were performed including pre-
existing medical and/or surgical conditions (such as
renal disease, rheumatic disease, cervical procedures,
cardiac disease) in the full model but were not found
to be significant predictors. Sensitivity analysis was
also performed excluding women with missing values.
Of the variables in the final model, only smoking dur-
ing pregnancy had missing values (N = 23); the results
remained unchanged after exclusion of those cases
(see Additional file 6).
We performed additional analyses to examine the ac-
curacy of the final model among subgroups of women
that may be under-represented in our population. We
applied the final model to women with singleton vs.
multiple pregnancy (see Additional file 7); the predictive
accuracy for each subgroup was similar to the overall
model performance (AUC 0.71 [0.69, 0.73] and AUC
0.77 [0.73, 0.81], respectively). Similarly, we applied
the model to women admitted at 24–31 weeks vs.
32–34 weeks gestation (see Additional file 8). The
predictive accuracy was similar for women admitted
at 24–31 weeks (AUC 0.72 [0.71, 0.74]), however, we
could not test all model parameters for the subgroup
of women admitted later due to low sample size.
Discussion
Main findings
Our large retrospective cohort study included women
admitted to a tertiary hospital for conditions that put
them at high risk for preterm birth, primarily at 24+0
and 29+6 weeks gestation. Approximately 49% delivered
within 7 days after admission, while 51% delivered after
7 days (14% delivered at term). We constructed a parsi-
monious predictive model to identify women who are at
risk of delivery within the next 7 days in order to opti-
mise administration of antenatal corticosteroids. The
model had a fair predictive accuracy (AUC of 0.73), good
calibration capacity and stratification ability, and it was
internally validated using a bootstrap method. Although
the predictive accuracy of our model was recognised to
be fair, it is based on information collected in routine
clinical care and it would significantly improve optimal
Table 3 Stratification ability of the predictive model to identify women with and without the outcome (delivery within 7 days)
Delivery within 7 days Delivery after 7 days Total
Predicted
probability
N Calibration
(% in probability
category)
Stratification
(% of all women
with outcome)
N Calibration
(% in probability
category)
Stratification
(% of all women
without outcome)
0–14.9% 14 6.0 1.0 219 94.0 14.2 233
15.0–19.9% 34 15.1 2.3 191 84.9 12.4 225
20.0–49.9% 392 41.2 26.6 560 58.8 36.4 952
50.0–64.9% 668 59.7 45.3 450 40.3 29.2 1118
≥65.0% 365 75.4 24.8 119 24.6 7.7 484
Total 1473 100 1539 100 3012
Table 4 Prognostic accuracy of delivery within 7 days at various cut-off points of predicted probability
Predicted probability (%) <15.0a <27.0 <50.0 <65.0
Number of women 233 510 1410 2528
N women delivered at ≤7 days (N = 1473 overall) 14 56 440 1108
N women delivered at >7 days (N = 1539 overall) 219 454 970 1420
Sensitivity 99.1% (98.4–99.4) 96.2% (95.1–97.1) 70.1% (67.7–72.4) 24.8% (22.6–27.1)
Specificity 14.2% (12.6–16.1) 29.5% (27.3–31.8) 63.0% (60.0–65.4) 92.3% (90.8–93.5)
False positive rate 85.8% (83.9–87.4) 70.5% (68.2–72.7) 37.0% (34.6–40.0) 7.7% (6.4–9.2)
False negative rate 0.9% (0.6–1.6) 3.8% (2.9–4.9%) 29.9% (27.6–32.3) 75.2% (72.9–77.4)
Positive predictive value 52.5% (50.6–54.4) 56.6% (54.7–58.6) 64.5% (62.1–66.8) 75.4% (71.4–79.0)
Negative predictive value 94.0% (90.2–96.4) 89.0% (86.0–91.5) 68.9% (66.3–71.2) 56.2% (54.2–58.1)
Positive likelihood ratio 1.16 (1.13–1.18) 1.37 (1.32–1.41) 1.90 (1.76–2.04) 3.93 (3.15–4.91)
Negative likelihood ratio 0.07 (0.04–0.11) 0.13 (0.10–0.17) 0.47 (0.43–0.52) 0.82 (0.79–0.84)
ae.g., if women with predicted probability <15% were considered at low-risk of delivery within 7 days, the sensitivity of the prognostic tool would be 99.1% while
the specificity would be 14.2
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steroid treatment on admission, (from 47.9% to 62.1% in
our cohort) by decreasing the number of women who do
not but should have received steroids (false negative rate).
The proportion of women with optimal treatment could
be maximised further with a different probability cut-off,
recognising that the ideal trade-off between sensitivity and
specificity will depend on the clinician’s and patient’s view
of potential benefits and harms associated with either pro-
viding or postponing treatment.
Interpretation
Optimising antenatal corticosteroid use requires ac-
curate identification of women who will deliver within
7 days and benefit from this treatment. However,
preterm birth is notoriously difficult to predict [19].
Meta-analyses of individual prognostic factors for pre-
term delivery showed that fetal fibronectin, absence of
fetal breathing movements, and cervical length have
potential for diagnostic use [20]. However, recent
studies have shown that fetal fibronectin testing does
not have an optimal clinical utility, as it does not pre-
vent preterm birth nor prevent adverse perinatal out-
comes among women with threatened pretem labour,
and is further associated with increased cost [21, 23, 24].
Only fetal breathing movements as a prognostic test
consistently yielded a likelihood ratio of a highly
informative test (LR+ >10). However, these meta-
analyses included very heterogeneous studies examin-
ing spontaneous preterm delivery within 24 h, 7, and
10 days among women with preterm labour [18, 20].
In contrast to our study, these predictors were exam-
ined as individual tests, and not in combination with
other determinants of early preterm delivery, and as
such could not be used to estimate the full range of
probability of delivery. Only a few studies focused dir-
ectly on predictive modeling of early delivery among
selected groups of women, including those with mul-
tiple pregnancies [39] or those transferred from one
hospital to a higher-level hospital [26]. The latter
study identified predictors of delivery within 48 h of
transfer, of which seven were similar to our result,
with the addition of sonographic length of uterine
cervix (a shorter length indicated a higher probability
of delivery). Other studies reporting the association
between preterm birth and preterm pre-labour rup-
ture of membranes, prolapsed membranes, vaginal
bleeding, cervical dilatation, preterm labour, older ma-
ternal age (>40 years), higher parity, or smoking are
consistent with our results [20, 32]. However, these
studies did not focus on predictive probability of pre-
term birth for individual women. Inclusion of these
known key risk factors as predictors in our model
thus increases its face validity.
Strengths and limitations
A strength of this study is that it includes a large popu-
lation dataset with detailed clinical information collected
at the time of admission to the hospital with threatened
preterm birth, the point in time at which clinicians must
decide whether to give antenatal corticosteroids so that
they will have the maximal effect by 48 h before
delivery. However, there are limitations to our study.
First, the time of admission was not recorded in the
CPN database, and thus our outcome potentially
included women delivering within 7 days and 23 h
after admission. Second, the predictive model is based
solely on patient and pregnancy characteristics at the
time of admission and the reason(s) for admission.
The predictive probability of delivery within 7 days is
relevant to the event of admission for hospital care,
and needs to be reassessed based on events that
occur afterwards. For example, a low probability of
early delivery may lead to a decision not to adminis-
ter corticosteroids at admission; however, subsequent
ruptured membranes during hospitalization would
prompt reassessment of risk. Unfortunately, we did
not have detailed follow-up information required to
construct a time-varying model for multiple reassess-
ment of the decision about timing of birth. Third, we
did not account for inter-centre variability recognising
differences between centres, although we tried to
limit this by excluding any practice-related predictors
to increase generalisability. Fourth, we used internal
validation to estimate the generalisability of our
model. However, external validation (for example, in a
similar cohort of women at risk of preterm delivery,
or women admitted at 32–34 weeks for which there
were few cases) is needed to better assess the
performance of the predictive model in other settings.
Finally, we did not have reliable information on pre-
pregnancy body mass index and assisted reproductive
technology use, which may constitute important risk
factors (41.9% and 76.6% of values were missing,
respectively).
Conclusion
In conclusion, we propose a useful tool to improve
prediction of delivery within 7 days at the time of
admission among women with threatened preterm
birth primarily at 24+0 and 29+6 weeks. Until the dis-
covery of novel biomarkers can improve prediction,
such a tool can significantly improve rates of optimal
steroid use by increasing the proportion of women
who receive steroids within 7 days prior to delivery,
and decrease rates of suboptimal steroid use by not
immediately treating women with a very low probabil-
ity of delivery within 7 days
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